InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (6 ops.)
Browse the full record of transactions filed by Chard Daniel R, Chairman & CEO. Director active across 1 companies, notably MEDIFAST INC. In total, 14 disclosures have been published. Total volume traded: €1.5m. The latest transaction was filed on 5 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
€74,950431.078 shares@ €173.86580.054% mcap4.3% of flow
Common Stock
SEC:0001104659-22-058937:0·
Ideal exit: 30 Jan 2023 (T+270)
€112,513690.274 shares@ €162.99750.081% mcap6.5% of flow
Common Stock
SEC:0001104659-22-048540:0·
Ideal exit: 1 Nov 2022 (T+270)
08,509 shares0
Common Stock
SEC:0001104659-22-036227:0·
€282,4281,804 shares@ €156.55650.20% mcap16.2% of flow
Common Stock
SEC:0001104659-22-026864:0·
24,072 shares
Common Stock
SEC:0001104659-22-000895·
24,072 shares
Common Stock
SEC:0001104659-22-000895:0·
090,610 shares0
Common Stock
SEC:0001104659-21-143174·
090,610 shares0
Common Stock
SEC:0001104659-21-143174:0·
€130,604600 shares@ €217.67270.094% mcap20.6% of flow
Common Stock
SEC:0001562180-21-004412·
€130,604600 shares@ €217.67270.094% mcap7.5% of flow
Common Stock
SEC:0001562180-21-004412:0·
€67,909300 shares@ €226.3620.049% mcap10.7% of flow
Common Stock
SEC:0001104659-21-082800·
€67,909300 shares@ €226.3620.049% mcap3.9% of flow
Common Stock
SEC:0001104659-21-082800:0·
€436,0961,847 shares@ €236.11070.31% mcap68.7% of flow
Common Stock
SEC:0001104659-21-081619·
€436,0961,847 shares@ €236.11070.31% mcap25.1% of flow
Common Stock
SEC:0001104659-21-081619:0·
14 of 14 declarations
About Chard Daniel R
Daniel R. Chard is Chairman and CEO of Medifast Inc. He is responsible for the strategic direction and management of the company's operations. With significant experience in the health and wellness industry, Daniel plays a key role in the growth and innovation of Medifast. His leadership is essential to achieving the company's objectives.
